Company Filing History:
Years Active: 1991-1993
Title: Ronald G Schoner: Innovator in Recombinant DNA Technology
Introduction
Ronald G Schoner is a notable inventor based in Monrovia, IN (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant DNA expression vectors. With a total of 2 patents, his work has advanced the understanding and application of genetic engineering.
Latest Patents
Schoner's latest patents focus on methods to produce recombinant proteins using innovative expression vectors. One of his key inventions is a method that incorporates novel recombinant DNA expression vectors containing both transcriptional and translational activating sequences. These vectors are designed to enhance the expression of DNA coding for functional polypeptides, particularly bovine growth hormone. The translational activating sequences include a ribosome binding site, which facilitates high-level expression of the desired proteins. Additionally, his inventions provide transformed microbial host cells capable of producing bovine growth hormone and other functional polypeptides at elevated levels.
Career Highlights
Ronald G Schoner has had a distinguished career, working with Eli Lilly and Company, a leading pharmaceutical firm. His expertise in recombinant DNA technology has positioned him as a key player in the development of biopharmaceuticals. His innovative approaches have contributed to advancements in the production of therapeutic proteins.
Collaborations
Schoner has collaborated with various professionals in his field, including his coworker Brigitte E Schoner. Their joint efforts have furthered research and development in biotechnology, particularly in the area of recombinant proteins.
Conclusion
In summary, Ronald G Schoner is a prominent inventor whose work in recombinant DNA technology has led to significant advancements in biotechnology. His contributions continue to impact the field, particularly in the production of therapeutic proteins.